Article info

Download PDFPDF

Original article
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
  1. Correspondence to Professor Martin R Cowie, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK; m.cowie{at}imperial.ac.uk
View Full Text

Citation

Kansal AR, Sorensen SV, Gani R, et al
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

Publication history

  • Accepted December 15, 2011
  • First published March 15, 2012.
Online issue publication 
March 15, 2012

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.